Nanostructured lipid carriers in cancer therapy: Advances in passive and active targeting strategies
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Nanostructured lipid carriers (NLCs) offer enhanced drug delivery for cancer therapy. These carriers improve tumor targeting through passive and active strategies, advancing precision oncology.
Area Of Science
- Biomedical Engineering
- Nanotechnology
- Oncology
Background
- Nanostructured lipid carriers (NLCs) are advanced drug delivery systems with improved drug solubility, stability, and controlled release capabilities.
- NLCs are increasingly explored for cancer therapy, focusing on passive and active tumor targeting to enhance treatment efficacy.
- Precision oncology aims to tailor cancer treatments to individual patients, requiring sophisticated drug delivery platforms.
Purpose Of The Study
- To comprehensively review the application of NLCs in cancer therapy, emphasizing passive and active targeting strategies.
- To analyze how NLC formulation, targeting methods, and stimuli-responsive designs impact therapeutic outcomes in oncology.
- To discuss the potential of NLCs as a versatile platform for advancing targeted cancer treatment.
Main Methods
- Literature review of recent studies on NLC formulation, targeting mechanisms, and therapeutic applications in cancer.
- Analysis of passive targeting via the enhanced permeability and retention (EPR) effect and active targeting using ligand-mediated approaches.
- Examination of lymphatic-targeting and stimuli-responsive NLCs for improved drug delivery and site-specific release.
Main Results
- NLCs facilitate enhanced tumor-specific drug delivery through both passive (EPR effect) and active (ligand-mediated) targeting.
- Lymphatic-targeting NLCs show potential for improved delivery to metastatic sites, while stimuli-responsive NLCs enable controlled release.
- Advances in NLC composition and functionalization significantly impact drug loading, biodistribution, and therapeutic efficacy.
Conclusions
- NLCs represent a highly adaptable and promising platform for precision cancer therapy.
- Optimization of NLC formulation, functionalization, and clinical translation is crucial for realizing their full potential in targeted oncology.
- Continued research into NLCs can lead to more effective and personalized cancer treatment strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.